MarketCap
Facebook
X
Telegram
Veracyte P/B Ratio | VCYT
Annual P/B Ratio Veracyte
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.32 | 2.52 | 1.64 | 1.56 | 2.55 | 7.38 | 5.13 | 8.2 | 5.91 | 3.6 | 3.28 | 4.24 | 1.09 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.2 | 1.09 | 3.8 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
0.474 | - | -6.63 % | $ 13.9 M |  USA |
 |
FSD Pharma
HUGE
|
1.66 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Codexis
CDXS
|
2.19 | $ 1.42 | 0.33 % | $ 124 M | USA |
 |
Synthetic Biologics
SYN
|
0.0679 | - | 1.32 % | $ 16.2 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.9 | - | - | $ 2.02 B | USA |
 |
I-Mab
IMAB
|
0.202 | - | - | $ 866 M |  China |
 |
Corner Growth Acquisition Corp.
COOL
|
65.3 | - | -0.89 % | $ 114 M | USA |
 |
AgeX Therapeutics
AGE
|
7.09 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Qilian International Holding Group Limited
QLI
|
1.2 | - | -6.08 % | $ 184 M | China |
 |
Happiness Biotech Group Limited
HAPP
|
0.115 | - | 1.35 % | $ 17.8 M | China |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
15 | - | -13.47 % | $ 169 M | France |
 |
Cue Biopharma
CUE
|
1.11 | $ 27.67 | 2.63 % | $ 2.62 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M |  Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
0.036 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
7.43 | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
6.8 | - | - | $ 4.9 B |  Britain |
 |
Завод ДИОД
DIOD
|
0.549 | - | - | - |  Russia |
|
Galera Therapeutics
GRTX
|
-0.0532 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
173 | - | -18.52 % | $ 27.3 M | Britain |
 |
Hepion Pharmaceuticals
HEPA
|
0.141 | - | -18.79 % | $ 39.3 K | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
MorphoSys AG
MOR
|
12.7 | - | 2.43 % | $ 254 M | Germany |
 |
Editas Medicine
EDIT
|
7.55 | $ 3.08 | 0.33 % | $ 273 M | USA |
 |
Ardelyx
ARDX
|
9.72 | $ 3.71 | 1.06 % | $ 894 M | USA |
 |
Affimed N.V.
AFMD
|
2.34 | - | -34.95 % | $ 21.5 M | Germany |
 |
EyePoint Pharmaceuticals
EYPT
|
0.00377 | $ 4.57 | 0.21 % | $ 335 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 23.66 | 0.04 % | $ 3.01 B | USA |
 |
Assembly Biosciences
ASMB
|
1.49 | $ 36.13 | 4.38 % | $ 405 M | USA |
 |
Fate Therapeutics
FATE
|
0.585 | $ 2.42 | 0.61 % | $ 287 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-17.8 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
0.539 | - | - | $ 12.5 M |  Belgium |
 |
Adial Pharmaceuticals
ADIL
|
0.248 | $ 6.66 | 5.38 % | $ 4.45 M | USA |
 |
Fortress Biotech
FBIO
|
1.25 | $ 2.71 | 0.04 % | $ 75.6 M | USA |
 |
Generation Bio Co.
GBIO
|
0.879 | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
Anika Therapeutics
ANIK
|
1.12 | $ 21.0 | 2.08 % | $ 301 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0503 | - | -4.36 % | $ 27 M | USA |
 |
Gracell Biotechnologies
GRCL
|
1.09 | - | - | $ 3.37 B | China |
 |
Axsome Therapeutics
AXSM
|
98.2 | $ 208.35 | 0.16 % | $ 10.4 B | USA |
 |
GlycoMimetics
GLYC
|
-1.57 | - | 9357.83 % | $ 1.01 B | USA |
 |
AnaptysBio
ANAB
|
4.17 | $ 57.46 | 2.9 % | $ 1.65 B | USA |
 |
Aeterna Zentaris
AEZS
|
1.12 | - | 5.93 % | $ 314 M | Canada |
 |
AVROBIO
AVRO
|
-0.402 | - | 1083.1 % | $ 745 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.92 | $ 66.43 | 0.04 % | $ 12.7 B | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |